Abstract
The activation of interferon-regulatory-factor-1 (IRF-1) hasbeen applied to regulate the cell growth of BHK cells. Theconstitutively expressed IRF-1-estrogen receptor fusion protein(IRF-1-hER) activated by the addition to the culture medium ofan estrogen analogue (estradiol), enabled IRF-1 to gain itstranscriptional activator function. By using a dicistronicstabilised self-selecting construct it was possible to controlcell proliferation. With the addition of 100 nM of estradiol at the beginning of the exponential phase, the IRF-1 activationled to a rapid cell growth inhibition. Two days after estradioladdition cell concentration was still maintained but a decreasein cell viability was observed. This cell response isindependent on clone (producer and non-producer) and culturesystem (static and stirred cultures). Specificrecombinant-protein productivity of the producer clone was notsignificantly altered. Control experiments confirmed that IRF-1activation effect was not due to the addition of estradiol per se, estradiol solvent or serum concentration. The extent ofcell growth inhibition is dependent on estradiol concentrationand estradiol addition time, although a decrease in cellviability was always observed. Reducing the time span ofestradiol exposure allowed the decrease in the cell viability tobe controlled and the stationary inhibited phase to be extended:when the time of contact between the cells and estradiol isreduced cell viability increases, archieving values similar tothose obtained if no estradiol is added. During this recoveryphase the cells passed two different phases: first a stationaryphase extension where cell growth was still inhibited, followedby an increase of cell concentration. The IRF-1 system isreversible. This pattern can be repeated for an extended period when estradiol addition and removal are repeated, showing acyclic response. Thus, it is possible to modulate the IRF-1effect by manipulating cycles of addition/removal of estradioland in this way the stationary phase can be maintained.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahluwalia BS, Westney LS & Rajguru SU (1995) Alcohol inhibits cell mitosis in G2–M phase in cell cycle in a human lymphocytes in vitro study. Alcohol 12 (6): 589–592.
Bajaj SP, Rapaport SI & Brown SF (1981) Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem, 256(1): 253–259.
Broze GJ Jr & Majerus PW (1980) Purification and properties of human coagulation factor VII. J Biol Chem, 255 (4): 1242–1247.
Gothelf Y, Raber J, Chen L, Schattner A, Chebath J & Revel M (1991) Terminal differentiation of myeloleukemic M1 cells induced by IL-6: role of endogenous interferon. Lymphokine Cytokine Res 10 (5): 369–375.
Harada H, Fujita T, Miyamoto M, Kimura T, Maruyama M, Furia A, Miyata T & Taniguchi T (1989) Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729–739.
Harada H, Takahasshi E-I, Itoh S, Harada K, Hori T-A & Taniguchi T (1994) Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for the gene network in the interferon system. Mol Cell Biol 14 (2): 1500–1509.
Kasajima N & Tsutsui T (1990) Cytotoxicity of ethyl alcohol on cultured mammalian cells. Shigaku 78 (1): 83–88.
Kirchhoff S, Schaper F & Hauser H (1993) Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res 21: 2881–2889.
Kirchhoff S, Koromilas A, Schaper F, Grashoof M, Sonenberg N & Hauser H (1995) IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11: 439–445.
Kirchhoff S, Kröger A, Cruz H, Tümmler M, Schaper F, Köster M & Hauser H (1996) Regulation of cell growth by IRF-1 in BHK-21 cells. Cytotechnology 22: 147–156.
Kimura T, Katsutoshi N, Penninger J, Kitagawa M, Harada H, Matsuyama T, Tanaka N, Kamijo R, Vilcek J, Mak T & Taniguchi T (1994) Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264: 1921–1924.
Koromilas AE, Roy S, Barber GN, Katze MG & Sonenberg N (1992) Malignant transformation by a mutant of the IFNinducible ds-RNA-dependent protein kinase. Science 257: 1685–1689.
Köster M, Kirchhoff S, Schaper F & Hauser H (1995) Proliferation control of mammalian cells by the tumor suppressor IRF-1. Cytotechnology 18: 67–75.
Lengyel P (1993) Tumor-suppressor genes: news about the interferon connection. Proc Natl Acid Sci USA 90: 5893–5895.
Moreira JL, Alves PM, Aunins JG & Carrondo MJT (1994) Changes in animal cell natural aggregates in suspended batch cultures. Appl Microbiol Biotechnol 41: 203–209.
Pellegrine S & Schindler C (1993) Early events in the signalling by interferons. TIBS 18: 338–342.
Tanaka T, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak T & Taniguchi T (1994) Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829–839.
Watanabe N, Sakakibara J, Hovanessian A, Taniguchi T & Fujita T (1991) Activation of IFN-β promoter element by IRF-1 requires a posttranscriptional event in addition to IRF-1 synthesis. Nucleic Acids res 16: 4421–4428.
Wigler M, Silverstein S, Lee L-S, Pellicer A, Cheng Y & Axel R (1977) Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11(1): 223–232.
Wilman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF & Taniguchi T (1993) Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259: 968–971.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carvalhal, A.V., Moreira, J.L., Cruz, H. et al. Manipulation of culture conditions for BHK cell growth inhibition by IRF-1 activation. Cytotechnology 32, 135–145 (2000). https://doi.org/10.1023/A:1008139304964
Issue Date:
DOI: https://doi.org/10.1023/A:1008139304964